Reproductive factors and risk of Parkinson’s disease in women: preliminary results from the French prospective cohort E3N.
Objective: Objective: To evaluate whether reproductive factors and use of exogenous hormones are associated with the risk of Parkinson’s disease (PD) in women. Background: Background:…Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease
Objective: To investigate the potential beneficial effects of estrogen on nigrostriatal dopaminergic neuron degeneration in postmenopausal drug-naïve Parkinson’s disease. Background: Epidemiologic studies have revealed that…In vivo and In vitro study of 17β estradiol against amyloid beta neurotoxicity in synaptosomes of aging female rats : A therapeutic potential drug for Alzheimer’s disease
Objective: The aim of the present study was to determine the effects of neuropeptide, neurokinin B (NKB) and amyloid beta fragment Aβ (25-35) on 17β…Does having more children really delay Parkinson’s age of onset in women?
Objective: Childbirth has been proposed to be protective of Parkinson’s (PD), in that having a higher number of children is associated with a later age…Lifetime exposure to estrogen and risk for progressive supranuclear palsy
Objective: To investigate the protective effect of estrogen on progressive supranuclear palsy (PSP). Background: Animal and human epidemiologic studies of Parkinson’s disease and Alzheimer’s dementia have…Modulation and mechanism for the neuroprotective effects of 17-beta-estradiol: Relevance to depressive symptoms in Parkinson’s disease
Objective: The objective of this study was to investigate neuroprotective potential of 17β estradiol (E2) treatment on the activities of acetylcholinesterase and monoamine oxidase, membrane…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.